Elevance Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Premiums & Annuity Revenue	164,639	144,166	142,854	133,229	117,373
Total Interest & Dividend Income	2,194	2,051	1,825	1,485	1,378
Other Revenue	32,293	30,593	26,661	21,885	19,892
Total Revenue	199,126	176,810	171,340	156,599	138,643
Revenue Growth (YoY)	12.62%	3.19%	9.41%	12.95%	13.76%
Policy Benefits	148,223	127,567	124,330	116,642	102,571
Amortization of Goodwill & Intangibles	628	580	885	767	441
Selling, General & Administrative	41,978	38,800	36,236	30,728	26,604
Total Operating Expenses	190,829	166,947	161,451	148,137	129,616
Operating Income	8,297	9,863	9,889	8,462	9,027
Interest Expense	-1,403	-1,185	-1,030	-855	-802
EBT Excluding Unusual Items	6,894	8,678	8,859	7,607	8,225
Merger & Restructuring Charges	-55	-268	-752	-7	-202
Gain (Loss) on Sale of Assets	-	201	-	-	-
Asset Writedown	-129	-41	-392	-	-7
Legal Settlements	-	-666	-	-	-
Other Unusual Items	-	-	-	-	-21
Pretax Income	6,710	7,904	7,715	7,600	7,995
Income Tax Expense	1,049	1,933	1,724	1,712	1,846
Earnings From Continuing Ops.	5,661	5,971	5,991	5,888	6,149
Minority Interest in Earnings	1	9	-4	6	9
Net Income	5,662	5,980	5,987	5,894	6,158
Net Income to Common	5,662	5,980	5,987	5,894	6,158
Net Income Growth	-5.32%	-0.12%	1.58%	-4.29%	34.69%
Shares Outstanding (Basic)	224	232	236	240	244
Shares Outstanding (Diluted)	225	233	237	243	247
Shares Change (YoY)	-3.56%	-1.90%	-2.22%	-1.62%	-2.95%
EPS (Basic)	25.28	25.81	25.38	24.56	25.26
EPS (Diluted)	25.21	25.68	25.22	24.28	24.95
EPS Growth	-1.83%	1.82%	3.87%	-2.69%	38.77%
Free Cash Flow	3,174	4,552	6,765	7,247	7,277
Free Cash Flow Per Share	14.13	19.55	28.50	29.85	29.48
Dividend Per Share	6.840	6.520	5.920	5.120	4.520
Dividend Growth	4.91%	10.13%	15.63%	13.27%	18.95%
Operating Margin	4.17%	5.58%	5.77%	5.40%	6.51%
Profit Margin	2.84%	3.38%	3.49%	3.76%	4.44%
Free Cash Flow Margin	1.59%	2.57%	3.95%	4.63%	5.25%
EBITDA	9,040	10,522	10,949	9,538	9,844
EBITDA Margin	4.54%	5.95%	6.39%	6.09%	7.10%
D&A For EBITDA	743	659	1,060	1,076	817
EBIT	8,297	9,863	9,889	8,462	9,027
EBIT Margin	4.17%	5.58%	5.77%	5.40%	6.51%
Effective Tax Rate	15.63%	24.46%	22.35%	22.53%	23.09%
Revenue as Reported	199,125	177,011	171,340	156,595	138,639

Updated Jan 28, 2026. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.

SEC Filings: 10-K · 10-Q